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chromatography–mass
spectrometry (LC–MS/MS)Abstract The metabolic fate of nicotine using the cell cultures of microorganisms, mushroom and
plants was explored using LC–MS/MS analysis. The study demonstrated parallels to phase I
mammalian metabolism of nicotine and reported that nicotine was biotransformed into its
N-oxide by Streptomyces fradiae culture. Moreover, it was metabolized in Pleurotus ostreatus cul-
ture into nornicotine, norcotinine and b-nicotyrine; whereas, cotinine and its 30-hydroxylated
derivative were the identiﬁed nicotine metabolic products in Pimpinella anisum cell culture.
However, the microbial culture of Agaricus bisporus bioconverted nicotine into one of its
derived-carcinogenic nitrosamines which is ‘‘4-(methylnitrosamino)-4-(3-pyridyl)butanal’’.
Mushroom and plant cell cultures were thus proven to be competent to microbial cultures in bio-
converting nicotine into many of its previously reported metabolites. Convincingly, the obtained
results highlighted the prospect of utilizing other species which are intrinsically-endowed with
unique biocatalytic systems, such as mushrooms and plants, in the drug metabolic studies.
ª 2015 Production and hosting by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.1. Introduction
The inherent enzymatic bioconversion process in mammals
known as ‘‘metabolism’’ involves the biotransformation of a
wide range of xenobiotics into speciﬁcally-modiﬁed structures
via both oxidative and conjugative biotransformation path-
ways.1–3 Analogously, the biocatalytic systems of other species
94 A.R. Khattab et al.such as microorganisms and plants were reported to produce
chemical changes on compounds that are not their natural sub-
strates.4 There are several reports that highlighted the intrinsic
potential of microbes to mimic the mammalian drug metabo-
lism due to the involvement of comparable monooxygenase
systems.5,6 Moreover, it was found that the enzymatic system
of plant cell cultures has the potential to perform special bio-
transformation reactions to produce its characteristic sec-
ondary metabolites. Such cultures also retain the ability to
transform exogenous compounds into new products that are
hardly obtained by chemical means.7
Regarding the nicotine metabolism, it is mostly carried out
in the liver through its cytochrome P450 isoenzymes (such as
CYP2A6), aldehyde oxidase and ﬂavin monooxygenase
(FMO).8 In humans, 70% of nicotine is oxidized to cotinine
by cytochrome P450 and aldehyde oxidase, 4% is oxidized dif-
ferently of which only a small fraction of nicotine is metabo-
lized to nornicotine, 9% is excreted unchanged in the urine,
while the metabolic fate of the remaining 17% is still
unidentiﬁed.9,10
It is worth noting that previous nicotine metabolic studies
were aimed to explore its metabolic fate using various liver
microsomal preparations and microbial cultures.11–13
However, there is a scarce nicotine biotransformation work
using plant suspension culture. Biotransformation of nicotine
was studied using some Nicotiana species such as Nicotiana
tabaccum cv. Wisconsin-38 in which the conversion of nicotine
into nornicotine was optimized to 100% efﬁciency.14
The present study was designed to explore the bioconver-
sion efﬁciency of some microorganism cultures as well as the
mushroom and plant cell suspension cultures toward a selected
naturally-occurring alkaloid ‘‘nicotine’’. The obtained results
were correlated with the previously reported nicotine mam-
malian metabolites.
2. Experimental
2.1. Materials and reagents
(S)-nicotine was purchased from Sigma–Aldrich Chemie
GmbH, Buchs, Switzerland. HPLC-grade acetonitrile
(Scharlau Chemie S.A., Sentmenat, Spain), HPLC-grade
methanol, formic acid and ultra-pure water (Sigma–Aldrich
Chemie GmbH, Buchs, Switzerland) were used. All other
chemicals were of analytical grade.
2.2. Tested microbial and plant cultures
The preliminary screening study involved the use of about ﬁf-
teen microbial strains, namely: Cunninghamella blakesleeana
MR 198, C. blakesleeanaNRRL 1369, Penicillium chrysogenum
ATCC 10002, P. vermiculatum NRRL 1009, P. purpureus U1
193, Streptomyces fradiae (lab isolate), Aspergillus niger
NRRL 328, A. ﬂavus NRRL 501, A. ochraceous NRRL 405,
A. ﬂaviceps ATCC 11013, A. alliaceous NRRL 315,
Saccharomyces cerevisiae NRRL Y-12632, Rhodotorula rubra
NRRL Y-1592, Gymnascella citrina NRRL 6050 and
Rhizopus species ATCC 36060 as well as the mycelia cultured
from the fruit bodies of two edible mushroom species:
Pleurotus ostreatus (oyster mushroom) and Agaricus bisporus
(button mushroom). The microorganisms were obtained fromtwo sources: American Type Culture Collection, Maryland,
USA (ATCC) and Northern Regional Research Laboratories,
Department of Agriculture, Peoria, Illinois, USA (NRRL).
Besides, several plant cell suspension cultures were also
examined for their biotransformation capability of nicotine,
which are the cell suspension cultures obtained from leaves
of Ocimum basilicum L., Echinacea purpurea and Vinca minor
L., besides, fruits of Coriandrum sativum L. and Pimpinella
anisum.
2.3. Biotransformation protocol
2.3.1. For microbial cultures
Two week-old microbial slants were used to inoculate sterilized
liquid culture medium consisting of 10 g dextrose, 10 ml
glycerol, 5 g yeast extract, 5 g peptone, 5 g K2HPO4, 5 g
NaCl and 1000 ml distilled water. The pH was adjusted to
6.0 before sterilization at 121 C for 15 min. The microbial cul-
tures were incubated at 25 C with rotary shaking at 150 rpm
for 48 h3. Nicotine was then added in a concentration of
10 mg/ﬂask (250 ml) using acetone as a solvent. The
incubation was allowed to continue for 15 days. After
which, the cultures were exhaustively extracted with
chloroform after basiﬁcation with ammonium hydroxide.
Both drug and culture controls were treated similarly. The
formed metabolites were detected by TLC analysis using a
solvent system of chloroform–ethanol–methanol–0.5 M
NaOH (30:15:2:1.5, v/v) and Dragendorff’s reagent to visual-
ize the alkaloidal spots.
2.3.2. For mushroom cultures
Mycelia from mushroom stock culture maintained on Potato
Dextrose Agar (PDA) petri-dishes were transferred into auto-
claved Mushroom Complete Medium (MCM) consisting of
20 g/L glucose, 2 g/L yeast extract, 2 g/L peptone, 0.46 g/L
KH2PO4, 1 g/L K2HPO4, 0.5 g/L MgSO4Æ7H2O and 1000 ml
distilled water at pH 5.5, by punching out 5 mm of the agar
plate culture with self-designed cutter. The mushroom cultures
were then incubated at 25 C for 24 h in the dark.15 Nicotine
was added using the same solvent and concentration men-
tioned before. The incubation was then allowed to continue
for 7 days at 25 C with rotary shaking at 150 rpm. The culture
extraction and TLC analysis were performed as mentioned
before.
2.3.3. For plant cell suspension cultures
The callus tissues belonging to the different plants under study
were grown on MS static media supplemented with 2,4-
dichlorophenoxyacetic acid (1.0 ppm) for 3 weeks and then
transferred into appropriate liquid MS medium supplemented
with 30 g/L sucrose and benzyladenine (1.0 ppm). The cultures
were grown under 16 h photoperiod at 23 ± 1 C on a gyra-
tory shaker at 100 rpm and subcultured every 4 weeks. The
same concentration of nicotine was added to the cultures
and periodical samples were withdrawn.16 At the end of the
experiment, the biotransformation cultures and their controls
were lyophilized. The lyophilized cultures (200–250 mg) were
then homogenized with 3 ml MeOH and extracted with
10 ml of 3% sulfuric acid in an ultrasonic bath for 45 min.
The extracts were centrifuged at 4000 rpm, for 10 min, the
supernatant layer was extracted with chloroform. The aqueous
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ide and extracted with 3 · 10 ml chloroform. The combined
chloroformic extracts were dried over anhydrous sodium sul-
fate and concentrated on a rotary evaporator.
2.4. Instrumentation
 Identiﬁcation of the metabolites was carried out using
Agilent Triple Quad LC–MS/MS Model 6460 Mass
Spectrometer. The residue of each extract was dissolved in
HPLC grade methanol in a concentration of 10 mg/ml.
Aliquots of 10 ll of each sample were injected. The chro-
matographic separation was performed using a reversed-
phase HPLC Zorbax SB-C18 column (5 lm,
150 mm · 4.6 mm, Agilent) which was held in an oven at
30 C.
 Two elution systems were used:Figure 1 LC–MS/MS total ion chromatograms of the biotransform
P. ostreatus (B) and A. bisporus (C), and the plant cell culture of P. a System No. 1: Elution solvent composed of acetoni-
trile/water (10:90, v/v) at ﬂow rates of 0.2 and 1.3 ml/min
was used for the analysis of biotransformation cultures of
S. fradiae and A. bisporus, respectively.
 System No. 2: Elution buffers were A, water with 0.1% for-
mic acid, and B, acetonitrile with 0.1% formic acid. The
gradient elution started at 5% B for 5 min and continued
with a percentage of B and time as follows: 95% B at
37 min, 95% B for 8 min at a ﬂow rate of 0.2 ml/min, which
was used for the analysis of biotransformation cultures of
P. ostreatus and P. anisum.
 The ESI interface was operated in positive ionization mode
in a scanning range (m/z of 50–700). The Agilent 6460 QQQ
ESI JetStream source parameters were set as the following
parameters: gas temperature: 300 C, gas ﬂow: 5 l.h1, neb-
ulizer: 45 psi, sheath gas temp: 250 C, sheath gas ﬂow:
11 L h1, capillary voltage: +4 kV, nozzle voltage: 500 Vation experiments using: the microbial cultures of S. fradiae (A),
nisum (D).
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ment control were performed by the MassHunter software
version V4.00 (Agilent).
3. Results and discussion
The microbial cultures of S. fradiae, P. ostreatus and
A. bisporus in addition to the plant cell suspension culture of
P. anisum were found to establish nicotine biotransformation
as revealed by the preliminary TLC analysis of their respective
extracts; accordingly, they were subjected to LC–MS/MS
analysis. The LC–MS/MS+ESI total ion chromatograms of
the four biotransformation experiments are depicted in Fig. 1.
3.1. N-Oxidation of nicotine
Nicotine N-oxide was found to be the metabolic product of
nicotine in S. fradiae culture as revealed by the preliminary
TLC analysis [the metabolite had Rf value of 0.12 that was
comparable to that reported for nicotine N-oxide in theFigure 3 Full scan product ion mass spectra of the precursor ions hav
of the peak eluted at 43.648 min (C).
Figure 2 +ESI MS/MS spectra of the peaksliterature (Rf = 0.08)].
17 Besides, the +ESI MS/MS spectrum
of the new metabolic peak eluted at 7.44 min (Fig. 1A)
revealed a [M+H]+ at m/z 179 and product ions at m/z
147.8, 132, 129.9 and 105.8 (Fig. 2A) which were consistent
with the published +ESI mass fragmentation data of nicotine
N-oxide.18 However, the chromatographic peak eluted at
16.39 min (Fig. 1A) represented the nicotine, as inferred by
its characteristic mass fragmentation pattern shown in
Fig. 2B, which was consistent with the published data, (m/z:
132, 130, 106 and 84).18 Hence, the biotransformation of
nicotine by S. fradiae culture was shown to be simulative to
N-oxidative reaction of the phase I mammalian metabolism
of nicotine. This is the ﬁrst report for Streptomycetes to
perform such a metabolic reaction of nicotine, as other
Streptomycetes (Z6 and Z8 strains) were reported to
biodegrade nicotine in the tobacco waste.193.2. N-Demethylation and dehydrogenation of nicotine
TLC analysis of the culture extract of P. ostreatus revealed the
presence of four major spots having Rf values of 0.40, 0.54,ing (A) m/z of 149 and (B) m/z of 163, and +ESI MS/MS spectrum
eluted at (A) 7.439 min and (B) 16.397 min.
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cotine (Rf = 0.35), norcotinine (Rf = 0.50), nicotine
(Rf = 0.77) and b-nicotyrine (Rf = 0.87), respectively in the
literature.17 Thus, they were the plausible nicotine biotransfor-
mation products. Accordingly, full product ion scan was per-
formed using the precursor ions having m/z of 149, 163
and159, which correspond to the protonated molecular masses
of the previously mentioned nicotine metabolites.
The product ion mass spectrum of the precursor ion having
m/z 149 (Fig. 3A) displayed a mass fragmentation pattern
identical to that reported for the metabolite ‘‘nornicotine’’,
(m/z: 130, 117 and 80).18,20 However, the precursor ion having
m/z 163, (Fig. 3B) produced six characteristic fragment ions at
m/z 136, 133, 130.1, 117.3, 105.9 and 77.2, which matched the
reported +ESI mass fragmentation data of norcotinine in the
literature (m/z: 136.1, 133.0, 130.4, 116.7, 106.4 and 77.4).21
Furthermore, the bioconversion of nicotine into b-
nicotyrine was conﬁrmed from the mass fragmentation pattern
of the weak peak eluted at 43.65 min which revealed a
[M+H]+ at m/z 159 (Fig. 3C). On +ESI-MS2 fragmentation,
b-nicotyrine was reported to display two distinctive product
ions at m/z 144 and 132 which were in accordance with the
obtained mass fragmentation data.18 It was reported that b-
nicotyrine was identiﬁed as a urinary metabolite of nicotine
in dogs and rats.22–24 Hence, the microbial culture of P. ostrea-
tus was found to be efﬁcient in biotransforming nicotine into
three metabolites: nornicotine (via N-demethylation), norco-
tinine (via N-demethylation and formation of nornicotine, fol-
lowed by C-oxidation) and b-nicotyrine (via dehydrogenation).Figure 4 Full scan product ion mass spectra of precur
Figure 5 +ESI MS/MS spectrum3.3. C-oxidation of nicotine
Two nicotine metabolites, represented by the chromatographic
peaks eluted at 21.44 and 21.72 min, were identiﬁed in the nico-
tine biotransformation experiment using P. anisum cell suspen-
sion culture shown in Fig. 1D. The mass spectrum of the ﬁrst
metabolic peak, eluted at 21.44 min, produced a mass fragmen-
tation pattern with a [M+H]+ at m/z 193 accompanied by
daughter ions at m/z 174.8, 133.7 and 118.4 (Fig. 4A), which is
consistent with the published mass fragmentation data of
trans-30-hydroxycotinine in the literature (m/z: 175, 134 and
118).18 This metabolite was also identiﬁed in A. bisporus
biotransformation culture (Fig. 1C), which is represented by
peak 1C.
However, the second metabolic peak, which is eluted at
21.72 min, in Fig. 1D, exhibited a mass spectrum with a
[M+H]+ at m/z 177 and product ions at m/z 146.2, 118.1,
98.0 and 80.2 (Fig. 4B) which were in good agreement with
the reported product ions of the main metabolite of nicotine
‘‘cotinine’’ (m/z: 146, 118, 98 and 80).203.4. Carcinogenic nitrosation reaction of nicotine
The +ESI total ion chromatogram of the extract of
A. bisporus biotransformation culture (Fig. 1C) revealed the
presence of a new weak metabolic peak eluted at 5.45 min.
The +ESI MS/MS spectrum of that peak showed a prominent
molecular ion peak at m/z 207.9, and Na+ adduct atm/z 229.9,sor ions having (A) m/z of 193 and (B) m/z of 177.
of the peak eluted at 5.45 min.
Figure 6 Microbial and plant cell culture metabolites of nicotine.
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and 106.2 (Fig. 5). By the aid of the available biochemical
databases HMDB (http://www.hmdb.ca/), mass fragmentation
behavior was found to be consistent with that of 4-(methylni
trosamino)-4-(3-pyridyl)butanal ‘‘NNAL’’.25 This was further
endorsed by matching its reported mass spectral data.26
NNAL, the potent pancreatic carcinogen, is considered to be
one of the tobacco smoke-derived nitrosamines which is acti-
vated by human cytochrome P450s. Smokers as well as non-
smokers when exposed to sidestream cigarette smoke excrete
NNAL and its glucuronide conjugate in their urine. Besides,
NNAL was proved to be the major metabolite of N-nitrosa
mine-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
‘‘NNK’’, which is another nicotine-derived nitrosamine.10
Thus, it could be proposed that nicotine was ﬁrstly converted
into NNK, via a nitrosation reaction, which is ultimately
metabolized into NNAL in A. bisporus culture.
In summary, the obtained nicotine metabolites can be
sketched collectively along with their respective biocatalysts
and the accomplished metabolic reactions in Fig. 6.
4. Conclusion
Mushroom and plant cell cultures were thus substantiated to
be biocatalytically-competent to microbial cultures in trans-
forming nicotine into its phase I mammalian metabolites pro-
duced via the N-oxidative metabolic route. In view of that, the
present study poses a perspective in the utility of the intrinsic
biocatalytic systems of mushroom and plant cultures as being
feasible simulating models to the drug metabolic fate in mam-
malian system.
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